MedPath

Maia Pharmaceuticals, Inc.

Maia Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Private
Established
2013-01-01
Employees
1
Market Cap
-
Website
http://maiapharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Daptomycin

Approval Date
Dec 4, 2024
FDA

Baclofen (Intrathecal)

Approval Date
Nov 8, 2023
FDA

Sincalide

Approval Date
Nov 1, 2023
FDA

SODIUM PHENYLACETATE AND SODIUM BENZOATE

Approval Date
Jul 5, 2023
FDA

Sodium Phenylacetate and Sodium Benzoate

Approval Date
Jan 16, 2023
FDA

Bortezomib

Approval Date
Sep 22, 2021
FDA

Angiomax RTU

Approval Date
Nov 5, 2019
FDA

Levothyroxine Sodium

Approval Date
Jan 30, 2019
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.